Publicacions destacades

• The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities

  Boni J; Rubio-Perez C; López-Bigas N; Fillat C; de la Luna S ;

  Referència:

  Cancers 2020.

• Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses

  Raimondi, Giulia; Mato-Berciano, Ana; Pascual-Sabater, Silvia; Rovira-Rigau, Maria; Cuatrecasas, Miriam;

  (...)

  Sanchez-Cabus, Santiago; Begthel, Harry; Boj, Sylvia F; Clevers, Hans; Fillat, Cristina.

  Veure llistat complet d'autors

  Referència:

  Ebiomedicine 2020.

• Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses

  Brugada-Vilà P; Cascante A; Lázaro MÁ; Castells-Sala C; Fornaguera C;

  Rovira-Rigau M; Albertazzi L; Borros S; Fillat C.

  Referència:

  Theranostics 2020.

• DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth

  Luna, Jeroni; Boni, Jacopo; Cuatrecasas, Miriam; Bofill-De Ros, Xavier; Nunez-Manchon, Estela;

  Gironella, Meritxell; Vaquero, Eva C; Arbones, Maria L; de la Luna, Susana; Fillat, Cristina.

  Referència:

  Gut 2019.

• Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

  Rovira-Rigau M; Raimondi G; Marín MÁ; Gironella M; Alemany R;

  Fillat C .

  Referència:

  Molecular Therapy 2019.

• Zeb1 in stromal myofibroblasts promotes Kras-driven development of pancreatic cancer.

  Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M;

  Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC .

  Referència:

  Cancer Research 2018.

• Implications of MicroRNAs in Oncolytic Virtherapy

  Bofill-De Ros, Xavier; Rovira-Rigau, Maria; Fillat, Cristina;;

  Referència:

  Frontiers In Oncology 2017.

• Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies

  Villanueva, Eneko; Navarro, Pilar; Rovira-Rigau, Maria; Sibilio, Annarita; Mendez, Raul;

  Fillat, Cristina.

  Referència:

  Nature Communications 2017.

• Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitness

  Villanueva E.; Martí-Solano M.; Fillat C.;

  Referència:

  Scientific Reports 2016.

• AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-KB mediated uPAR activation

  Victoria Maliandi, Maria; Mato-Berciano, Ana; Sobrevals, Luciano; Roue, Gael; Jose, Anabel;

  Fillat, Cristina.

  Referència:

  Molecular Cancer 2015.